InsiderSignal.AI

InsiderSignal.ai

EW - Edwards Lifesciences Corp

Insider Sale by Ullem Scott B. (CVP, CFO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Ullem Scott B., serving as CVP, CFO at Edwards Lifesciences Corp (EW), sold 13,000 shares at $84.92 per share, for a total transaction value of $1,103,896.00. Following this transaction, Ullem Scott B. now holds 306,017 shares of EW.

This sale represents a 4.00% decrease in Ullem Scott B.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, March 11, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 11, 2026, meaning the disclosure happened on the same day as the trade.

Edwards Lifesciences Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Ullem Scott B.

CVP, CFO

Scott B. Ullem is a Corporate Vice President and Chief Financial Officer (CFO) at Edwards Lifesciences Corporation (NYSE: EW), a position he has held since January 2014.[[1]](https://theorg.com/org/edwards-lifesciences/org-chart/scott-b-ullem)[[3]](https://www.zoominfo.com/p/Scott-Ullem/28842655)[[6]](https://www.edwards.com/about-us/our-leaders) In this role, he oversees finance as well as information technology, information security, risk management, indirect sourcing, and corporate services.[[3]](https://www.zoominfo.com/p/Scott-Ullem/28842655) Ullem recently engaged in insider trading at Edwards Lifesciences and has announced his plan to step down by mid-2026, transitioning to an advisory role thereafter.[[2]](https://www.medtechdive.com/news/Edwards-CFO-Scott-Ullem-steps-down-Q3/804447/)[[3]](https://www.zoominfo.com/p/Scott-Ullem/28842655)[[5]](https://ir.edwards.com/news/news-details/2025/Edwards-Lifesciences-Announces-CFO-Transition-Plan/default.aspx) Prior to Edwards, Ullem served as CFO and business unit leader at Bemis Company, Inc. from 2010 to 2013, and spent 17 years in investment banking as Managing Director at Goldman Sachs and Bank of America.[[1]](https://theorg.com/org/edwards-lifesciences/org-chart/scott-b-ullem)[[3]](https://www.zoominfo.com/p/Scott-Ullem/28842655) He holds a Master of Business Administration from Harvard Business School and a Bachelor of Arts in Political Science from DePauw University.[[1]](https://theorg.com/org/edwards-lifesciences/org-chart/scott-b-ullem)[[3]](https://www.zoominfo.com/p/Scott-Ullem/28842655) Ullem serves on the boards of directors at Illumina, egnite Health, and Berry Global, Inc., where he is on the Compensation and Audit Committees, and is a Henry Crown Fellow at the Aspen Institute.[[1]](https://theorg.com/org/edwards-lifesciences/org-chart/scott-b-ullem)[[3]](https://www.zoominfo.com/p/Scott-Ullem/28842655)

View full insider profile →

Trade Price

$84.92

Quantity

13,000

Total Value

$1,103,896.00

Shares Owned

306,017

Trade Date

Wednesday, March 11, 2026

4 days ago

SEC Filing Date

Wednesday, March 11, 2026

HEALTHCAREMEDICAL DEVICES

About Edwards Lifesciences Corp

Company Overview

No company information available
View news mentioning EW

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4696252

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime